Helen M. Thackray

CIK 1589725 · View on SEC EDGAR ↗

Insider

First SEC filing: Jan. 9, 2014 · Latest: Jan. 9, 2014

On this page

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 27 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

27 other filings hidden
Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
May 14, 2024 BCRX P 30,000 $5.86 $175,800 272,139 Direct +12.39% Acquired 67.8% (price as of 2026-08-20)
April 3, 2023 BCRX S 10b5-1 7,000 $8.29 $58,030 207,275 Direct -3.27% Disposed 18.6% (price as of 2026-08-20)
Dec. 15, 2022 BCRX S 10b5-1 3,125 $10.89 $34,031 133,275 Direct -2.29% Disposed -9.7% (price as of 2026-08-20)
April 1, 2022 BCRX S 10b5-1 7,600 $16.20 $123,120 136,400 Direct -5.28% Disposed -39.3% (price as of 2026-08-20)
Dec. 8, 2017 CBIO S 2,000 $15.01 $30,020 148,615 Direct -1.33% Disposed -98.9% (price as of 2026-08-20)
Sept. 18, 2017 CBIO S 2,000 $13.00 $26,000 150,615 Direct -1.31% Disposed -98.7% (price as of 2026-08-20)
May 25, 2017 CBIO S 2,000 $15.57 $31,140 152,615 Direct -1.29% Disposed -98.9% (price as of 2026-08-20)
May 19, 2017 CBIO S 10b5-1 2,000 $12.14 $24,280 154,615 Direct -1.28% Disposed -98.6% (price as of 2026-08-20)
Oct. 3, 2016 CBIO S 10b5-1 100 $7.01 $701 156,615 Direct -0.06% Disposed -97.6% (price as of 2026-08-20)
Oct. 3, 2016 CBIO S 10b5-1 3,900 $7.00 $27,300 156,715 Direct -2.43% Disposed -97.6% (price as of 2026-08-20)
July 20, 2016 CBIO S 10b5-1 2,000 $8.00 $16,000 160,615 Direct -1.23% Disposed -97.9% (price as of 2026-08-20)
July 6, 2016 CBIO S 10b5-1 6,796 $6.68 $45,397 162,615 Direct -4.01% Disposed -97.5% (price as of 2026-08-20)
July 5, 2016 CBIO S 10b5-1 10,136 $7.01 $71,053 169,411 Direct -5.65% Disposed -97.6% (price as of 2026-08-20)
July 1, 2016 CBIO S 10b5-1 5,068 $7.40 $37,503 179,547 Direct -2.75% Disposed -97.7% (price as of 2026-08-20)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
Dec. 19, 2024 BCRX Emp. Stock Option (Right to Buy) Common Stock (260,950) $7.39 Dec. 19, 2034 260,950 Acquired
Dec. 14, 2023 BCRX Emp. Stock Option (Right to Buy) Common Stock (238,000) $6.43 Dec. 14, 2033 238,000 Acquired
Dec. 19, 2022 BCRX Emp. Stock Option (Right to Buy) Common Stock (238,000) $10.63 Dec. 19, 2032 238,000 Acquired
Dec. 14, 2021 BCRX Emp. Stock Option (Right to Buy) Common Stock (205,000) $11.43 Dec. 14, 2031 205,000 Acquired
March 31, 2021 BCRX Emp. Stock Option (Right to Buy) Common Stock (400,000) $10.17 March 31, 2031 400,000 Acquired
Jan. 20, 2021 CBIO Employee Stock Option (right to buy) Common Stock (69,000) $3.81 Jan. 19, 2031 69,000 Acquired
May 12, 2020 BCRX Automatic Stock Option Grant [F1] Common Stock (40,000) $5.41 May 12, 2030 40,000 Acquired
Jan. 22, 2020 CBIO Employee Stock Option (right to buy) Common Stock (120,000) $4.72 Jan. 21, 2030 120,000 Acquired
Sept. 20, 2019 BCRX Non-Qualified Stock Option Common Stock (40,000) $2.86 Sept. 20, 2029 40,000 Acquired
Jan. 17, 2019 CBIO Employee Stock Option (right to buy) Common Stock (100,000) $10.59 Jan. 16, 2029 100,000 Acquired
Jan. 10, 2018 CBIO Employee Stock Option (right to buy) Common Stock (75,000) $20.03 Jan. 9, 2028 75,000 Acquired
Jan. 4, 2017 CBIO Employee Stock Option (right to buy) Common Stock (75,000) $6.33 Jan. 3, 2027 75,000 Acquired
Jan. 7, 2016 CBIO Employee Stock Option (right to buy) Common Stock (71,000) $5.22 Jan. 6, 2026 71,000 Acquired
Jan. 8, 2015 CBIO Employee Stock Option (right to buy) Common Stock (71,000) $7.15 Jan. 7, 2025 71,000 Acquired
Jan. 9, 2014 CBIO Stock Option (right to buy) Common Stock (112,692) $8.00 Jan. 9, 2024 112,692 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 1 holding

Securities held when first becoming an insider, per SEC Form 3.

Date Ticker Security Shares Ownership
Jan. 9, 2014 CBIO Common Stock 184,615 Direct

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

BCRX

M.D. Chief R&D Officer
Fiscal year Salary Bonus Stock awards Option awards Non-equity incentive Pension change Other Total
2022 $554,200 — $861,030 $1,792,902 $277,100 — $12,700 $3,497,932
2021 $425,125 $236,500 $1,519,920 $4,395,101 $298,125 — $6,625 $6,881,396

CBIO

Fiscal year Salary Bonus Stock awards Option awards Non-equity incentive Pension change Other Total
2014 $345,005 — — — $90,694 — — $1,126,501

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.